APA (7th ed.) Citation

Strik, A. S., Brink, G. R., Ponsioen, C., Mathot, R., Löwenberg, M., & D'Haens, G. R. (2017). Suppression of anti-drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 45(8), 1128. https://doi.org/10.1111/apt.13994

Chicago Style (17th ed.) Citation

Strik, A. S., G. R. Brink, C. Ponsioen, R. Mathot, M. Löwenberg, and G. R. D'Haens. "Suppression of Anti-drug Antibodies to Infliximab or Adalimumab with the Addition of an Immunomodulator in Patients with Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics 45, no. 8 (2017): 1128. https://doi.org/10.1111/apt.13994.

MLA (9th ed.) Citation

Strik, A. S., et al. "Suppression of Anti-drug Antibodies to Infliximab or Adalimumab with the Addition of an Immunomodulator in Patients with Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics, vol. 45, no. 8, 2017, p. 1128, https://doi.org/10.1111/apt.13994.